WASHINGTON — Outraged Republican and Democratic lawmakers on Wednesday grilled the head of pharmaceutical company Mylan about the significant cost increase of its life-saving EpiPen and the profit for a company with sales in excess of $11 billion. Mylan CEO Heather Bresch held up an EpiPen as she told the House Oversight and Government Reform Committee...